Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Saxenda is another GLP-1 receptor agonist FDA ... compounded drugs marketed as semaglutide. These drugs aren’t FDA approved, nor are they tested for safety, purity, or efficacy.

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...